Functional Precision Medicine and Precision Immune Oncology Strategies
August 25, 2025 @ 15:00 – 16:00 CEST
Prof Taskén will cover research on functional precision medicine using cancer drug sensitivity screening to guide clinical decisions and on tumor immune evasion mechanisms aiming for future precision immune oncology approaches.
Biography
Professor Kjetil Taskén has been key in building Norway’s national cancer precision medicine initiative, now coordinates the Cancer Mission PRIME-ROSE project for DRUP-like clinical trials across Europe and will lead the Work Package on treatment in the Joint Action for Precision Cancer Medicine to start Nov 2025. He has authored>300 publications and is an inventor of >20 patents (h-index >70). He won the King Olav V’s Prize for Cancer Research in 2016, the University of Oslo Innovation Prize in 2023, the Oslo University Hospital Excellent Researcher Award in 2024, and is Vice-President of the Norwegian Academy of Science and Letters. Current research is in tumor immune evasion mechanisms and functional precision medicine for different solid and blood cancers. Kjetil is also member of SciLifelab’s International Advisory Board (IAB).
Host: Janne Lehtiö
janne.lehtio@scilifelab.se
Google Calendar 
